Shijiazhuang Lonzeal Pharmaceuticals Co Ltd, based in China, is a pharmaceutical company.
One of their notable products is DOLUTEGRAVIR SODIUM, with a corresponding US DMF Number 42554.
Remarkably, this DMF maintains an Active status since its submission on September 26, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 14, 2025, and payment made on September 29, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II